CBLL1 and non-small cell lung carcinoma: CBLL1 has been reported to be overexpressed and associated with poor prognosis in non-small cell lung cancer (NSCLC) and esophageal cancer (EC) (Weng et al., 2019; Zhao et al., 2021).